GT Biopharma, Inc. - FORM 10-K - EX-21.1 - SUBSIDIARIES OF OXIS INTERNATIONAL, INC. - March 31, 2015

Attached files

file	filename
EXCEL - IDEA: XBRL DOCUMENT - GT Biopharma, Inc.	Financial_Report.xls
EX-14.1 - CODE OF ETHICS - GT Biopharma, Inc.	ex141.htm
EX-10.2 - EMPLOYMENT AGREEMENT OF ANTHONY CATALDO - GT Biopharma, Inc.	ex102.htm
EX-32.1 - CERTIFICATION SECTION 906 - GT Biopharma, Inc.	ex321.htm
EX-31.2 - CERTIFICATION SECTION 302 - GT Biopharma, Inc.	ex312.htm
EX-31.1 - CERTIFICATION SECTION 302 - GT Biopharma, Inc.	ex311.htm
EX-10.1 - EMPLOYMENT AGREEMENT OF STEVEN WELDON - GT Biopharma, Inc.	ex101.htm
EX-32.2 - CERTIFICATION SECTION 906 - GT Biopharma, Inc.	ex322.htm
10-K - OXIS INTERNATIONAL ANNUAL REPORT 2014 - GT Biopharma, Inc.	oxisannualreport2014.htm

Exhibit 21.1

SUBSIDIARIES OF OXIS INTERNATIONAL, INC.

As of December 31, 2014, the Company’s subsidiaries were as follows:

Name		Jurisdiction of incorporation

OXIS Therapeutics, Inc.		Delaware
OXIS Isle of Man Limited		Isle of Man
Oxis Consumer Products, LLC		Delaware
Oxis Biotech, Inc.		Delaware